Update on EU actions to support availability of medicines during COVID-19 pandemic

EMA

10 April 2020 - The continued availability of medicines is one of the most important priorities for EU authorities that are adopting measures to mitigate possible disruptions to the supply of medicines caused by the ongoing COVID-19 pandemic. 

The EU Executive Steering Group on Shortages of Medicines Caused by Major Events met virtually on 8 April to discuss ongoing activities aimed at ensuring a coordinated response to the challenges posed by the COVID-19 pandemic.

Read EMA press release

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , Europe , Supply , COVID-19